Sally C. Medley

Array ( [id] => 4349990 [patent_doc_number] => 06200559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Use of antibodies against MxA or MxB to determine levels of type I interferons in vivo' [patent_app_type] => 1 [patent_app_number] => 9/297475 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 2478 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200559.pdf [firstpage_image] =>[orig_patent_app_number] => 297475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254493 [patent_doc_number] => 06207814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them' [patent_app_type] => 1 [patent_app_number] => 9/382256 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 10870 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207814.pdf [firstpage_image] =>[orig_patent_app_number] => 382256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269846 [patent_doc_number] => 06323006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Recombinant human beta-CIS interferon' [patent_app_type] => 1 [patent_app_number] => 9/331260 [patent_app_country] => US [patent_app_date] => 1999-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4046 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323006.pdf [firstpage_image] =>[orig_patent_app_number] => 331260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297567 [patent_doc_number] => 06187304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Effects of IFN-.gamma. on cardiac hypertrophy' [patent_app_type] => 1 [patent_app_number] => 9/273099 [patent_app_country] => US [patent_app_date] => 1999-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 35 [patent_no_of_words] => 12655 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187304.pdf [firstpage_image] =>[orig_patent_app_number] => 273099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296747 [patent_doc_number] => 06180773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3' [patent_app_type] => 1 [patent_app_number] => 9/180077 [patent_app_country] => US [patent_app_date] => 1998-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3368 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180773.pdf [firstpage_image] =>[orig_patent_app_number] => 180077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353366 [patent_doc_number] => 06200780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Human interferon-.epsilon.(IFN-.epsilon.), a type I interferon' [patent_app_type] => 1 [patent_app_number] => 9/206903 [patent_app_country] => US [patent_app_date] => 1998-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 1980 [patent_no_of_words] => 32638 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200780.pdf [firstpage_image] =>[orig_patent_app_number] => 206903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154184 [patent_doc_number] => 06114145 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Synferon, a synthetic interferon' [patent_app_type] => 1 [patent_app_number] => 9/205264 [patent_app_country] => US [patent_app_date] => 1998-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19549 [patent_no_of_claims] => 149 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114145.pdf [firstpage_image] =>[orig_patent_app_number] => 205264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106365 [patent_doc_number] => 06057131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1)' [patent_app_type] => 1 [patent_app_number] => 9/186827 [patent_app_country] => US [patent_app_date] => 1998-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 14229 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057131.pdf [firstpage_image] =>[orig_patent_app_number] => 186827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209702 [patent_doc_number] => 06086867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Modulation of TGF-.beta. by TGF-.beta. type III receptor polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/183543 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 3 [patent_no_of_words] => 15026 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086867.pdf [firstpage_image] =>[orig_patent_app_number] => 183543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240549 [patent_doc_number] => 06136309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Antibodies against the interferon (IFN) .alpha./.beta. receptor (IFNAR2) that preferentially block the activity of IFN-.alpha.' [patent_app_type] => 1 [patent_app_number] => 9/171979 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7837 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136309.pdf [firstpage_image] =>[orig_patent_app_number] => 171979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214310 [patent_doc_number] => RE036755 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors' [patent_app_type] => 2 [patent_app_number] => 9/144502 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18053 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 69 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/036/RE036755.pdf [firstpage_image] =>[orig_patent_app_number] => 144502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209728 [patent_doc_number] => 06086869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Use of interferon-.beta. or .gamma. to treat retinal edema' [patent_app_type] => 1 [patent_app_number] => 9/101906 [patent_app_country] => US [patent_app_date] => 1998-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2430 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086869.pdf [firstpage_image] =>[orig_patent_app_number] => 101906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125877 [patent_doc_number] => 06120762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'C-terminal peptides of interferon .gamma.' [patent_app_type] => 1 [patent_app_number] => 9/102150 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5915 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120762.pdf [firstpage_image] =>[orig_patent_app_number] => 102150 [rel_patent_id] =>[rel_patent_doc_number] =>)